Filing Details
- Accession Number:
- 0001613103-25-000111
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-30 16:15:58
- Reporting Period:
- 2025-07-28
- Filing Date:
- 2025-07-30
- Accepted Time:
- 2025-07-30 16:15:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1613103 | Medtronic Plc | MDT | Electromedical & Electrotherapeutic Apparatus (3845) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1708062 | Skip Harry Kiil | 710 Medtronic Parkway Minneapolis MN 55432 | Evp & President Cardiovascular | No | Yes | No | No |
Transaction Summary
| Number of Shares After Transactions: | 41,318 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2025-07-28 | 7,612 | $0.00 | 41,318 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Performance Share Unit | Performance Share Units | Acquisiton | 2025-07-28 | 19,028 | $0.00 | 19,028 | $0.00 |
| Ordinary Shares | Stock Option (Right to Buy) | Acquisiton | 2025-07-28 | 53,671 | $0.00 | 53,671 | $91.97 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 19,028 | No | 4 | A | Direct | ||
| 53,671 | 2035-07-28 | No | 4 | A | Direct |
Footnotes
- Represents restricted stock units that vest 100% on the third anniversary of the date of grant.
- Includes 264 shares acquired through dividend reinvestment since the last report filed by the reporting person.
- Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
- Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028.
- The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 19,028 shares will be issued. If maximum performance metrics are achieved, 38,056 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
- These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
Billionaire Hedge Funds
